The second day of FE Healthcare Summit on August 19 which started on August 18, 2021 concluded with deliberations and panel discussions on subjects on revolutionary analysis, digital method to healthcare, diagnostics, emergency healthcare services in India, healthcare policy and investment in healthcare.
While delivering his Chief Guest address on Delhi government’s overall health initiatives and its huge fight against Corona, Satyendar Jain, Minister of Health, Government of Delhi spoke about supplying home isolation and plasma therapy through all the 4 covid waves and informed that in Delhi alone 30 lakh double Covid vaccine doses have been administered via its 400 centres which have the capacity of vaccinating 4 lakh individuals every day alongwith ramping up ICU beds from 6,000 beds to 12, 000 beds.
While delivering her crucial note address on the theme “Innovative Research pandemic and beyond. Global perspective, lessons and way forward for India,” Dr Soumya Swaminathan, Chief Scientist, World Health Organization (WHO) on the occasion of second day of Virtual FE Healthcare Summit which started from August 18 and will conclude on August 20, 2021 highlighted the reality that there are massive quantity of clinical trials on vaccine performed across the world and this has resulted in significant quantity of fragmented little inconclusive trials which has led to more confusion than really delivering the answers
“The solution lies in large platform trials like the WHO solidarity trial which has 30 countries and 500 hospitals of which many are in India participating which was able to test some of the repurposed drugs that were thought to have some potential for Covid -19 treatment. We are looking at launching a second solidarity trial which is looking at immuno modulatory drugs for people who are hospitalised with critical illness of Covid-19,” Dr Swaminathan mentioned.
While moderating a panel discussion on the subject of creating a digital 1st method to healthcare, Dr Rana Mehta from Price water residence Coopers Services LLP mentioned, “Though the Government Ayusman Bharat PMJAY scheme has given financial access to 500 million people, there is inadequacy in terms of healthcare infrastructure and doctors when it comes to addressing the pandemic crisis.Therefore digital transformation and intervention is very much required to address the challenge of Covid-19.”
Talking on digital transformation, Prashant Tandon, Founder, 1mg mentioned, “Covid-19 brought about a drastic change in the mindset of the healthcare stakeholders and made digital transformation viable when the supply chains were disrupted. It was a challenge but we could address the challenge with the help of digital interventions.”
During the session, Ritesh Talapatra Managing Director, Optum Global Solutions (India) Pvt Ltd mentioned, “There is always a challenge in terms of healthcare costs, quality and accessible healthcare. Digital transformation has allowed us to move towards value based care where costs are managed better by using the data of patients at Optum which we have developed over the past few decades.”
Echoing equivalent views, Narendra K Saini, Chief Data and Digital Officer, Lupin mentioned, “Covid -19 has allowed people to adopt digital technologies in a faster way which were earlier not acceptable as physical access to healthcare was pre-dominant. The digital transformation has brought down healthcare costs and also made healthcare delivery faster today.”
Sudhanshu Mittal, Head & Director, Technical Solutions – CoE IoT & AI: Lead – Digital Healthcare & Industry 4. – NASSCOM recommended that healthcare organizations and start off-ups must create digital technologies options maintaining the customers in thoughts.
While speaking on the Panel Discussion on the subject of The Diagnostic Play, Kuldeep Singh Sachdeva, Regional Director – The Union South East Asia, International Union Against Tuberculosis and Lung Disease mentioned,“The main challenge lies in finding resources for drug resistant TB. There are challenges from resource, demand and supply side. Capacity in the public sector is not good as there are very few clinicians for the management and diagnosis of drug resistant TB. There is huge mortality in drug resistant TB because of the lack of right kind of diagnostics to use, when to use, where to use.”
According to Dr Arvind Lal, Chairman & Managing Director, Dr Lal Path Labs, “Private sector in India is conducting more than 70 percent consultations and diagnostics in TB based on the database managed by a robust centralised portal of the Government by the name NI-KSHAY. Our centralised TB cell is linked with NI-KSHAY and all our labs are conducting microscopy at the reference labs in Delhi, Bangalore, Kolkata and Mumbai are equipped with BSL -3 facility to test TB and also do drug sensitivity tests.”
‘
Talking about the TB manage programme, Dr Sudarsan Mandal Deputy Director General- Central TB Division, Ministry of Health & Family Welfare, Government of India mentioned, ”We have place TB manage programme on mission mode and we could notify 20 lakh patients in 2018 and 24 lakh patients in 2019 and we have place them below therapy protocol. There is a need to have to realize that one TB patient left untreated can spread infections to 15 individuals.”
Speaking at the session, Dr. A. Velumani Founder, Thyrocare mentioned, “There is a need for public private partnership in building logistical support for collection of sputum in terms of making TB diagnosis more effective in which state governments support is equally needed.”
Rashi Garg, General Manager, Cepheid India recommended that there is a need to have to create successful molecular and diagnostic tests to detect drug resistant TB early for timely therapy intervention.
While speaking on the panel discussion on Emergency Healthcare Services in India, Praveen Gowdru, CEO, VMEDO, “The emergency healthcare services were overwhelmed pan -India with our ambulatory care services getting 2000 calls per day as compared to 100 calls per day before Covid-19 pandemic.”
Dr. N K Venkataramana Founder Chairman & Director – Neurosciences, BRAINS Hospitals spoke about obtaining uniform emergency method and requirements to present crucial care even in instances of covid.
Dr Santosh Shetty, CEO, Kokilaben Hospital recommended that public private partnership was at the core of dealing with Covid -19 as non-Covid patients also necessary therapy interventions when it came to emergency services.
While speaking on the panel discussion on Emergency Healthcare Services in India, Jitendra Walia, CEO, KHG Health Services highlighted the reality that we have a total 19 lakh hospital beds out of which only 5 to 8% beds are crucial care beds out of which 50% have ventilators.
Kindly Login to discover FE Healthcare Summit at –
https://events.financialexpress.com/event/fe-healthcare-summit/virtual/login